ATAI Life Sciences NV ATAI:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 05/02/24 EDT
2.16quote price arrow up+0.03 (+1.41%)
Volume
1,632
Close
2.13UNCH (UNCH)
Volume
855,596
52 week range
1.02 - 2.85
Loading...
  • Open2.09
  • Day High2.18
  • Day Low2.06
  • Prev Close2.13
  • 52 Week High2.85
  • 52 Week High Date04/04/24
  • 52 Week Low1.02
  • 52 Week Low Date12/01/23

Key Stats

  • Market Cap353.636M
  • Shares Out166.03M
  • 10 Day Average Volume0.99M
  • Dividend-
  • Dividend Yield-
  • Beta0.97
  • YTD % Change51.06

KEY STATS

  • Open2.09
  • Day High2.18
  • Day Low2.06
  • Prev Close2.13
  • 52 Week High2.85
  • 52 Week High Date04/04/24
  • 52 Week Low1.02
  • 52 Week Low Date12/01/23
  • Market Cap353.636M
  • Shares Out166.03M
  • 10 Day Average Volume0.99M
  • Dividend-
  • Dividend Yield-
  • Beta0.97
  • YTD % Change51.06

RATIOS/PROFITABILITY

  • EPS (TTM)-0.28
  • P/E (TTM)-7.49
  • Fwd P/E (NTM)-2.80
  • EBITDA (TTM)-125.152M
  • ROE (TTM)-15.97%
  • Revenue (TTM)314,000.01
  • Gross Margin (TTM)-
  • Net Margin (TTM)-12,835.35%
  • Debt To Equity (MRQ)7.36%

EVENTS

  • Earnings Date05/07/2024
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On ATAI Life Sciences NV

 

Profile

MORE
ATAI Life Sciences NV is a Germany-based clinical-stage biopharmaceutical company. The Company engages in developing various treatments that focuses on various mental health disorders. The Company's therapeutic lead compound include PCN-101, a subcutaneous formulation of R-ketamine for the treatment of treatment-resistant depression (TRD); RL-007, a cholinergic, glutamatergic, and GABA-B receptor modulator to treat cognitive impairment associated with schizophrenia; DMX-1002...
Florian Brand
Chief Executive Officer, Co-Founder
Anne Johnson
Chief Financial Officer
Address
Wallstrasse 16
Berlin
10179
Germany

Top Peers

SYMBOLLASTCHG%CHG
TERN
Terns Pharmaceuticals Inc
5.29UNCHUNCH
ERAS
Erasca Inc
2.15UNCHUNCH
AVIR
Atea Pharmaceuticals Inc
3.83UNCHUNCH
NAUT
Nautilus Biotechnology Inc
2.67UNCHUNCH
BDTX
Black Diamond Therapeutics Inc
6.59UNCHUNCH